Perspective Therapeutics Announces Pricing of $80 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
May 24, 2024 08:01 ET
|
Perspective Therapeutics, Inc.
SEATTLE, May 24, 2024 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective” or the “Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced treatment...
Genelux Corporation Announces Pricing of Approximately $27.5 Million Underwritten Offering of Common Stock and Accompanying Warrants
May 24, 2024 08:00 ET
|
Genelux Corporation
Genelux Corporation Announces Pricing of Approximately $27.5 Million Underwritten Offering of Common Stock and Accompanying Warrants
BriaCell Doubles Progression-Free-Survival (PFS) and Reports Clinical Benefit Data at ASCO 2024
May 24, 2024 08:00 ET
|
BriaCell Therapeutics Corp.
83% intracranial objective response rate (iORR) with Bria-IMT™ in heavily pretreated advanced breast cancer patients with CNS metastasesMedian progression free survival (PFS) of 4.1 months in ADC...
Monopar Announces CFO Succession
May 24, 2024 08:00 ET
|
Monopar Therapeutics Inc.
WILMETTE, Ill., May 24, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage radiopharmaceutical company focused on developing innovative treatments for cancer...
Weebit Nano and Efabless collaborate to enable easy, affordable prototyping of innovative SoC designs
May 24, 2024 08:00 ET
|
Weebit Nano Ltd; Efabless Corporation
Weebit and Efabless are enabling Efabless chipIgnite users to integrate Weebit ReRAM advanced non-volatile memory in their SoC prototypes.
Canadian Large Cap Leaders Split Corp. Receives Approval for Normal Course Issuer Bid
May 24, 2024 08:00 ET
|
Ninepoint Partners LP
Not for distribution to United States newswire services or for dissemination in the United States TORONTO, May 24, 2024 (GLOBE NEWSWIRE) -- Ninepoint Partners LP (“Ninepoint”), on behalf of...
Fostering Social Connections in the Virtual Workplace
May 24, 2024 08:00 ET
|
The Conference Board of Canada
OTTAWA, May 24, 2024 (GLOBE NEWSWIRE) -- In the wake of the seismic shift towards hybrid and remote work models, some of the top concerns surfacing for Canadian organizations are those related to...
Oma Savings Bank Plc issues a EUR 250 million covered bond in a tap issue
May 24, 2024 08:00 ET
|
Oma Säästöpankki Oyj
OMA SAVINGS BANK PLC, STOCK EXCHANGE RELEASE 24 MAY 2024 AT 15:00 P.M. EET, OTHER INFORMATION DISCLOSED TO THE RULES OF THE EXCHANGE Oma Savings Bank Plc issues a EUR 250 million covered bond in a...
SOND INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sonder Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
May 24, 2024 08:00 ET
|
Bronstein, Gewirtz & Grossman, LLC
NEW YORK, May 24, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been...
CG Oncology to Present Positive Final Results from Phase 2 CORE-001 Study of Cretostimogene Grenadenorepvec in Combination with Pembrolizumab in BCG-Unresponsive High-Risk NMIBC at ASCO 2024 Annual Meeting
May 24, 2024 08:00 ET
|
CG Oncology Inc.
CG Oncology to Present Positive Final Results from Phase 2 CORE-001 Study of Cretostimogene Grenadenorepvec in Combination with Pembrolizumab
- May 24, 2024 07:48 ET Global Hormone Replacement Therapy Research Report 2024: A $35+ Billion Market by 2032 - Industry Trends, Share, Growth, Insight, Top Companies
- May 24, 2024 07:39 ET Global Personalized Medicine Market Research Report 2024-2032 Featuring Abbott Laboratories, GE Healthcare, Aadi Bioscience, Illumina, QIAGEN, Eli Lilly and Co, Takeda, AbbVie, F. Hoffmann-La Roche